Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

NCT00316511 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignancies
B-Cell Lymphoma

Interventions

DRUG: Aroplatin

Sponsor

Agenus Inc.